2020 年2 期 第28 卷
前沿进展单硝酸异山梨酯注射液治疗心血管疾病有效性及安全性的研究进展
Research progress on effectiveness and safety of isosorbide mononitrate injectionin treating cardiovascular disease
作者:孙成磊1 ,宋毅 1 ,程国良 1 ,耿长生 1 ,张营 2 ,张贵民 1
- 单位:
- 1.276000 山东省临沂市,国家手性制药工程技术研究中心;2.272067 山东省济宁市,济宁医学院精准医学研究院;通信作者:张贵民,E-mail:lunanzhangguimin@163.com
- Units:
- 1.National Chiral Pharmaceutical Engineering Technology Research Center,Linyi 276000,China;2.Institute of Precision Medicine,Jining Medical University,Jining 272067,China;Corresponding author:ZHANG Guimin,E-mail:lunanzhangguimin@163.com
- 关键词:
- 心血管疾病;硝酸异山梨酯;治疗结果;安全;综述
- Keywords:
- Cardiovascular diseases;Isosorbide dinitrate;Treatment outcome;Safety;Review
- CLC:
- R 54 R 743
- DOI:
- DOI:10.3969/j.issn.1008-5971.2020.02.017
- Funds:
摘要:
单硝酸异山梨酯属硝酸酯类药物,主要作用机制为扩张静脉容量血管、外周阻力血管,降低心脏前后负荷,减少心肌耗氧量等,主要用于治疗冠心病、心绞痛、心肌梗死、心力衰竭等心血管疾病。不同剂型单硝酸异山梨酯药动学不同,而单硝酸异山梨酯注射液具有剂量准确、起效快、生物利用度高等特点,且有效性较好、安全性较高。本文主要综述了单硝酸异山梨酯注射液治疗心血管疾病的有效性及安全性,以期为临床科学、合理地应用该药提供参考。
Abstract:
Isosorbide mononitrate,as one kind of nitrates,mainly used in treating cardiovascular disease,suchas coronary heart disease,angina pectoris,myocardial infarction and heart failure. Major action mechanism of isosorbidemononitrate involves dilating venous volume vessels and peripheral resistance vessels,reducing cardiac anteroposterior loadand myocardial oxygen consumption. Different dosage forms of isosorbide mononitrate have different pharmacokinetics,howeverisosorbide mononitrate injection has some characteristics of accurate dose,rapid onset,high bioavailability and so on,thus it iseffective and safe on clinic. This paper mainly reviewed the effectiveness and safety of isosorbide mononitrate injection in treatingcardiovascular disease,in order to provide a reference for its scientific and reasonable application on clinic.
ReferenceList: